Reactivation of cytomegalovirus (CMV) infection is most commonly a consequence of immunosuppression either by cytotoxic or T cell inhibitor drugs or by advanced human immunodeficiency virus (HIV) infection. In addition, disturbances of cytokine equilibrium may result in CMV antigenaemia and subclinical reactivation a few days after the onset of severe bacterial sepsisl. The full clinical significance of CMV infection complicating severe sepsis has yet to be ascertained, but life-threatening infections can arise in previously immunocompetent patients2. We report such a case.
CASE HISTORY
A woman aged 70 was admitted with a two-day history of diarrhoea, vomiting, breathlessness and confusion. Three days previously she had sustained a minor injury to her right great toe. Her medical history included hypertension, mild asthma and a well documented severe hypersensitivity reaction to penicillin.
On admission she was febrile (temperature 39°C), Glasgow coma scale 12 /15, blood pressure 130/90 mmHg, pulse 120 beats per minute, respiratory rate 40 per minute. The right foot was hot and tender. Blood gas analysis on humidified high flow oxygen therapy showed a respiratory acidosis with type I respiratory failure. Chest X-ray was consistent with adult respiratory distress syndrome. When blood had been taken for culture she was started on ceftriaxone, clindamycin and metronidazole. She was transferred to the intensive care unit where she was immediately intubated and ventilated. Blood methicillin-sensitive Staphylococcus aureus. Transthoracic echocardiography, abdominal ultrasound, gynaecological review and computerized tomography of the brain did not indicate other foci of infection. Cardiovascular instability and oliguria developed, requiring inotropic support and haemodialysis. Attempts to establish enteral feeding were unsuccessful because of large nasogastric aspirates and diarrhoea.
After 4 weeks in intensive care and slow initial improvement, her fever returned with the development of a Klebsiella pneumoniae ventilator-associated pneumonia. Melaena developed, followed by torrential rectal bleeding which caused the haemoglobin to drop from 10.5 g/dL to 7.9 g/dL. Upper gastrointestinal endoscopy showed only mild gastritis. Stool was negative for Clostridium difficile toxin. The bleeding continued and emergency mesenteric angiography showed no obvious source. In view of continued torrential rectal bleeding, an emergency laparotomy was undertaken, revealing a distended, bloodfilled colon. Subtotal colectomy with ileostomy was performed. The mucosa was haemorrhagic throughout. In addition, five areas of ulceration were identified at the hepatic flexure and mid-transverse colon (up to 11 mm diameter). Histological examination of the ulcers revealed moderate chronic inflammatory infiltrate with areas of thrombosed blood vessels and foci of endothelial proliferation. Some endothelial cells were enlarged with prominent 'purple' inclusions typical of CMV. Immunocytochemistry confirmed the presence of CMV in endothelial cells. There were no other signs of systemic CMV infection. Antibody tests for HIV were negative. Urine, sputum and heparinized whole blood were examined for CMV immediate early antigen by a direct immunofluorescence assay (Light Diagnostics): samples were prepared according to the manufacturer's instructions, incubated on human fetal lung cells in selective media and then incubated with conjugatelabelled monoclonal IgG 2a isotype antibodies to CMV immediate early antigen IEI and IE2 (MW 68-72 kDa, CMV AD 169 derived protein). After intubation, labelled antibody-antigen complexes were detected by fluorescence microscopy in urine but not in blood or sputum. Serological tests were suggestive of reactivation rather than primary infection: CMV IgM antibody negative, CMV IgG positive.
After three days the ileostomy infarcted and she returned to theatre for revision. Two further revisions were required before a viable ileostomy could be obtained. In view of her continued deterioration, intravenous ganciclovir was started, at a dose of 5 mg/kg twice daily. After two days' treatment the patient started bleeding profusely from the ileostomy site and received blood, fresh frozen plasma and platelets. Upper gastrointestinal endoscopy again showed no obvious bleeding point. She died later that day.
At necropsy the small-bowel mucosa was congested and haemorrhagic with small ulcerations. Because of autolysis and degeneration of mucosa, small-bowel CMV could not be confirmed or excluded. There were multiple infarcts in the kidneys and spleen and the mitral valve was calcified with multiple small thrombotic vegetations on the anterior leaf. It was postulated that small-bowel, renal and splenic infarcts had resulted from embolization of these vegetations. COMMENT Though seldom described in patients with no previous immunodeficiency state, CMV colitis is known to be associated with inflammatory bowel disease24. Most commonly it occurs in patients with impaired T cell function-for example, patients with AIDS or patients on cytotoxic chemotherapy. In the case described here, lifethreatening haemorrhage secondary to CMV colitis occurred after 4 weeks of intensive care in a critically ill patient with multiorgan failure due to serious bacterial sepsis. She had no history of inflammatory bowel disease or of cytotoxic or other immunosuppressive therapy, and was HIV-antibody negative. It therefore seems likely that CMV infection was reactivated as a result of severe bacterial sepsis. Although mild (possibly symptomless) reactivated infection may occur within four days of the onset of severe sepsis2, overt disease usually takes upwards of two weeks to develop in patients on immunosuppressive therapy3. CMV colitis should be considered in the differential diagnosis of rectal bleeding in critically ill patients irrespective of previous immune status. Respiratory syncytial virus (RSV) is the principal cause of bronchiolitis in infancy. In most cases the bronchiolitis is mild and self-limiting but in some the disease is severe and even fatal. In such severely affected infants, nebulized ribavirin is commonly tried. We have treated an infant successfully with intravenous ribavirin.
Intravenous ribavirin for infant bronchiolitis

CASE HISTORY
A nine-week-old boy weighing 2.76 kg was brought to hospital with a two-day history of cough, lethargy and poor feeding. He had been born at 28 weeks and ventilated, but had no chronic lung disease. From the onset of his illness he rapidly worsened and on arrival he was shocked and hypothermic. After initial resuscitation he developed increasing respiratory distress for which he was ventilated. White cell count on admission was 3 x 109/L, 72% lymphocytes. A chest radiograph showed bilateral pulmonary infiltrates; blood and urine bacterial cultures were negative; nasopharyngeal aspirates were positive by enzyme-linked immunosorbent assay for RSV antigens. Viral cultures were not performed. Attempts at treatment with nebulized ribavirin were abandoned because of unacceptable increases in ventilatory pressures. He was treated additionally with broad spectrum antibiotics and inotropic agents. By day 7 he was weaned off inotropes but remained difficult to ventilate. A five-day course of steroids, between days 8 and 13, was tried with no improvement. By day 17 he still required ventilatory support (pressure 25/3, rate 30, oxygen concentration 60%), radiographs showed further extension of infiltrates, and he remained RSV Children's Intensive Care Unit, Leicester Royal infirmary, Leicester LE2 6ER, UK Correspondence to: Dr David Luyt
